RecruitingNCT06806618
HAE Burden and Crisis Management
Survey Evaluating the Burden and Management of HAE Crises by Patients and Caregivers
Sponsor
University Hospital, Grenoble
Enrollment
300 participants
Start Date
Mar 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The study has been designed as a French, multicentric survey study to obtain data to describe the burden of on-demand treatment for patients with hereditary angioedema (HAE). The online survey assesses various aspects of HAE and in particular the burden of HAE from the patients' and caregivers' perspectives.
Eligibility
Min Age: 12 Years
Inclusion Criteria6
- For the patient population:
- Patients with a confirmed diagnosis of HAE with a deficit in the C1 inhibitor.
- Aged ≥12 years
- Having consulted for HAE in the last 3 months and with a medical file.
- For the caregiver population:
- \. A person identified by the patient as part of their support group and who provides support with the management of the patients HAE (including family members, friends, spouse, etc.)
Exclusion Criteria3
- For the patient population:
- Opposes to participating in the study.
- Patients is under guardianship or deprived of their liberty.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06806618
Related Trials
Donidalorsen Treatment in Children With Hereditary Angioedema
NCT072984473 locations
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
NCT0667988124 locations
A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries
NCT0725193324 locations
A Study of Navenibart in Participants With Hereditary Angioedema
NCT0684282379 locations
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
NCT070468061 location